Success Metrics

Clinical Success Rate
85.9%

Based on 61 completed trials

Completion Rate
86%(61/71)
Active Trials
10(10%)
Results Posted
49%(30 trials)
Terminated
10(10%)

Phase Distribution

Ph phase_1
4
4%
Ph phase_2
8
8%
Ph phase_4
11
11%
Ph phase_3
7
7%
Ph not_applicable
34
34%

Phase Distribution

4

Early Stage

8

Mid Stage

18

Late Stage

Phase Distribution64 total trials
Phase 1Safety & dosage
4(6.3%)
Phase 2Efficacy & side effects
8(12.5%)
Phase 3Large-scale testing
7(10.9%)
Phase 4Post-market surveillance
11(17.2%)
N/ANon-phased studies
34(53.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.6%

61 of 73 finished

Non-Completion Rate

16.4%

12 ended early

Currently Active

10

trials recruiting

Total Trials

99

all time

Status Distribution
Active(12)
Completed(61)
Terminated(12)
Other(14)

Detailed Status

Completed61
unknown14
Terminated10
Recruiting8
Withdrawn2
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
99
Active
10
Success Rate
85.9%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (6.3%)
Phase 28 (12.5%)
Phase 37 (10.9%)
Phase 411 (17.2%)
N/A34 (53.1%)

Trials by Status

completed6162%
recruiting88%
terminated1010%
unknown1414%
withdrawn22%
active_not_recruiting22%
not_yet_recruiting22%

Recent Activity

Clinical Trials (99)

Showing 20 of 99 trialsScroll for more
NCT05659381Phase 3

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

Recruiting
NCT02851706

Natural History of and Specimen Banking for People With Tumors of the Central Nervous System

Completed
NCT04948541Not Applicable

Effect Of Sleep Apnea Treatment On Temporo-Mandibular Disorders

Completed
NCT05938270Phase 1

A Study to Investigate the Biological Effects of Saruparib (AZD5305), Darolutamide, and in Combination in Men With Newly Diagnosed Prostate Cancer.

Recruiting
NCT05041907Phase 2

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Recruiting
NCT04858022Phase 2

Visual Acoustic Biofeedback for RSE Via Telepractice

Completed
NCT07286487Not Applicable

Glycyrrhetinic Acid and Acute Irritant Dermatitis

Not Yet Recruiting
NCT07268196

Impact of Liver Transplantation on Sexual Life and Function

Recruiting
NCT07263061

Time to Post-operative Recovery of Serum Albumin as a Predictor of Outcome in Major Hepato Pancreato Biliary Surgeries

Recruiting
NCT07261085

A Study to Learn How Paxlovid [Nirmatrelvir-ritonavir/PF-07321332] Works in COVID-19 Patients Who Are Elderly or Have Medical Conditions.

Active Not Recruiting
NCT03851406Not Applicable

Woodsmoke Particulate + Hypertonic Saline

Completed
NCT03189173Phase 2

Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea

Completed
NCT02237417Phase 4

Impact of Aripiprazole Once Monthly Medications on Changes in Brain Structure and Metabolism

Completed
NCT03099135Phase 3

A Long Term Follow-up Study in Participants Treated in a Preceding Phase 2 or 3 Study With a Regimen Containing Odalasvir and AL-335 With or Without Simeprevir for the Treatment of Hepatitis C Virus (HCV) Infection

Terminated
NCT06724861Not Applicable

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

Not Yet Recruiting
NCT05567237Not Applicable

Effects of Microcurrent Treatment With and Without Resistance Exercises

Recruiting
NCT06413420

SUNOSI® (Solriamfetol) Pregnancy Registry

Recruiting
NCT00112931Phase 3

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Completed
NCT04063085Not Applicable

The Assessment of the Use of Anti-Adhesion Agents to Prevent Pelvic Postoperative Adhesions

Completed
NCT05987917Not Applicable

Clinical and Histological Evaluation of BTL-785F Non-invasive Treatment for Facial Rejuvenation

Completed

Drug Details

Intervention Type
OTHER
Total Trials
99